Acorda Therapeutics Hits Ch. 11, Plans $185M Drug Sale

By Yun Park · April 2, 2024, 11:29 AM EDT

Neurological disorders drugmaker Acorda Therapeutics Inc. filed for Chapter 11 protection in New York bankruptcy court, with plans to sell its assets to another pharmaceutical company for $185 million....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Acorda Therapeutics, Inc.

Case Number

7:24-bk-22284

Court

New York Southern

Nature of Suit

Date Filed

April 01, 2024